Servier To Acquire Edgewise Therapeutics' Muscular Dystrophy Business

(MENAFN - PR Newswire) Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage ...